Everolimus trIal for Advanced prememopausaL Breast Cancer Patients

Clinical trial NCT02313051 · UNKNOWN

Trial details

NCT number: NCT02313051
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2014-12-01
Primary completion: 2016-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.